Stock A217730 KANGSTEM BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Kangstem Biotech Co., Ltd.

Equities

A217730

KR7217730001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
2,635 KRW -1.50% Intraday chart for Kangstem Biotech Co., Ltd. -0.94% +10.02%
Apr. 25 An undisclosed buyer agreed to acquire a 24.27% stake in Croen Inc. from Kangstem Biotech Co., Ltd. for KRW 2.8 billion CI
2023 Kangstem Biotech Co., Ltd.(KOSDAQ:A217730) dropped from S&P Global BMI Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
An undisclosed buyer agreed to acquire a 24.27% stake in Croen Inc. from Kangstem Biotech Co., Ltd. for KRW 2.8 billion
CI
Kangstem Biotech Co., Ltd.(KOSDAQ:A217730) dropped from S&P Global BMI Index
CI
Kang Stem Biotech to Raise 35.1 Billion Won via Shares Issuance; Shares Plunge 30%
MT
Kangstem Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kang Stem Biotech Co., Ltd. announced that it has received KRW 47.99962221 billion in funding from a group of investors
CI
Kang Stem Biotech Co., Ltd. announced that it expects to receive KRW 47.99962221 billion in funding from a group of investors
CI
Kang Stem Biotech Co., Ltd. cancelled the acquisition of 60% stake in Croen Inc.
CI
Kang Stem Biotech Co., Ltd. announced that it has received KRW 1.40 billion in funding
CI
Kang Stem Biotech Co., Ltd. agreed to acquire a 60% stake in Croen Inc. for KRW 2.7 billion.
CI
Kang Stem Biotech Co., Ltd. announced that it expects to receive KRW 1.40 billion in funding
CI
Kang Stem Biotech Co., Ltd. announced that it has received KRW 30 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, LIG Investment & Securities Co., Ltd., Investment Arm, and other investors
CI
Kang Stem Biotech Co., Ltd. announced that it expects to receive KRW 30 billion in funding from Kiwoom Securities Co., Ltd., Investment Arm, LIG Investment & Securities Co., Ltd., Investment Arm, and other investors
CI
ORIG3N, Inc and Kangstem Biotech Announce Collaboration to Study Neural Stem Cells
CI
Lutronic Corporation cancelled the sale of 4.11% stake in Kang Stem Biotech Co., Ltd.
CI
Kang Stem Biotech Co., Ltd.(KOSDAQ:A217730) added to S&P Global BMI Index
CI
Kang Stem Biotech Co., Ltd. has completed an IPO in the amount of KRW 12.00 billion.
CI
Kang Stem Biotech Co., Ltd. has filed an IPO in the amount of KRW 20.00 billion.
CI
Lutronic Corporation signed a contract to sell 4.11% stake in Kang Stem Biotech Co., Ltd. for KRW 2.4 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A217730 Stock
  4. News Kangstem Biotech Co., Ltd.